These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23947891)

  • 21. Protein translocation through the anthrax toxin transmembrane pore is driven by a proton gradient.
    Krantz BA; Finkelstein A; Collier RJ
    J Mol Biol; 2006 Feb; 355(5):968-79. PubMed ID: 16343527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression and characterization of the recombination anthrax lethal factor].
    Guo Q; Xu JJ; Dong DY; Fu L; Chen W
    Wei Sheng Wu Xue Bao; 2004 Dec; 44(6):749-51. PubMed ID: 16110953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein- and DNA-based anthrax toxin vaccines confer protection in guinea pigs against inhalational challenge with Bacillus cereus G9241.
    Palmer J; Bell M; Darko C; Barnewall R; Keane-Myers A
    Pathog Dis; 2014 Nov; 72(2):138-42. PubMed ID: 25044336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.
    Langer M; Duggan ES; Booth JL; Patel VI; Zander RA; Silasi-Mansat R; Ramani V; Veres TZ; Prenzler F; Sewald K; Williams DM; Coggeshall KM; Awasthi S; Lupu F; Burian D; Ballard JD; Braun A; Metcalf JP
    Infect Immun; 2012 Dec; 80(12):4374-87. PubMed ID: 23027535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of introducing a single charged residue into the phenylalanine clamp of multimeric anthrax protective antigen.
    Janowiak BE; Fischer A; Collier RJ
    J Biol Chem; 2010 Mar; 285(11):8130-7. PubMed ID: 20061382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insertion of anthrax protective antigen into liposomal membranes: effects of a receptor.
    Sun J; Vernier G; Wigelsworth DJ; Collier RJ
    J Biol Chem; 2007 Jan; 282(2):1059-65. PubMed ID: 17107945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.
    Sellman BR; Mourez M; Collier RJ
    Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.
    Sun J; Lang AE; Aktories K; Collier RJ
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4346-51. PubMed ID: 18334631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic effects of anthrax toxins in the rabbit model and the cardiac pathology induced by lethal toxin.
    Lawrence WS; Marshall JR; Zavala DL; Weaver LE; Baze WB; Moen ST; Whorton EB; Gourley RL; Peterson JW
    Toxins (Basel); 2011 Jun; 3(6):721-36. PubMed ID: 22069736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fighting anthrax with flies.
    Giagtzoglou N; Bellen HJ
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3013-4. PubMed ID: 16492749
    [No Abstract]   [Full Text] [Related]  

  • 31. Anthrax toxin protective antigen: inhibition of channel function by chloroquine and related compounds and study of binding kinetics using the current noise analysis.
    Orlik F; Schiffler B; Benz R
    Biophys J; 2005 Mar; 88(3):1715-24. PubMed ID: 15596516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phenylalanine clamp catalyzes protein translocation through the anthrax toxin pore.
    Krantz BA; Melnyk RA; Zhang S; Juris SJ; Lacy DB; Wu Z; Finkelstein A; Collier RJ
    Science; 2005 Jul; 309(5735):777-81. PubMed ID: 16051798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the N-terminal amino acid of Bacillus anthracis lethal factor in lethal toxin cytotoxicity and its effect on the lethal toxin neutralization assay.
    Verma A; Wagner L; Stibitz S; Nguyen N; Guerengomba F; Burns DL
    Clin Vaccine Immunol; 2008 Nov; 15(11):1737-41. PubMed ID: 18815235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
    Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
    J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
    Yan M; Roehrl MH; Basar E; Wang JY
    Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiological manifestations in mice exposed to anthrax lethal toxin.
    Culley NC; Pinson DM; Chakrabarty A; Mayo MS; LeVine SM
    Infect Immun; 2005 Oct; 73(10):7006-10. PubMed ID: 16177381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.